What new is coming and when?29 Jul 2021 11:55
Looking at the RNS from 4th May we can expect an update on this clinal trial fairly soon:
'As previously stated, over the next three months, Paraytec plans to conduct a longitudinal clinical study (where patients are monitored over time).'
I sense that this is an important part of the package for potential commercial partners. As we know discussions with commercial partners are taking place they must know this trial is in progress and I can't see why they would finalise a deal without seeing it's outcomes.
Also noteworthy, from the 23rd June RNS:
'A key advantage of the Paraytec test is its potential to distinguish between intact viral particles and residual RNA fragments. It is known that RNA fragments are present in nasal and pharyngeal epithelial cells and can yield a positive PCR test result for several weeks after peak viral load has passed.'
So a significant difference between our test and say current PCR is that it can more accurately tell when an infected subject stops being infectious - Overall an individuals status of infection and how long they have left - whether they just became infected but won't be sick for x days/won't be infectious for x days/will stop being infectious after x days. Data that allows experts to realistically challenge assumptions e.g. is 10 days self isolation correct?
Faster and smarter.
Key news and data is coming.